Priorities and preferences of advanced soft tissue sarcoma patients starting palliative chemotherapy: baseline results from the HOLISTIC study

Authors:

Abstract
No abstract available
Funding Information
  • Royal Marsden NHS Foundation Trust
  • GlaxoSmithKline
  • National Institute for Health Research
  • Novartis
  • Eli Lilly and Company
  • Bayer
  • Merck Sharp and Dohme United Kingdom

This publication has 40 references indexed in Scilit: